 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Design Therapeutics Inc. (DSGN)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-03-30 Purchase | 2021-04-01 4:15 pm | Design Therapeutics Inc. | DSGN | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Former 10% Owner | 750,000 | $20 | $15,000,000 | 5,114,844 (Indirect) | View |
| 2020-03-30 Purchase | 2021-04-01 6:12 pm | Design Therapeutics Inc. | DSGN | William Arsani Director | 700,000 | $20 | $14,000,000 | 2,732,501 (Indirect) | View |
| 2021-03-30 Purchase | 2021-04-01 6:14 pm | Design Therapeutics Inc. | DSGN | Thacker Justin VP | 17,500 | $20 | $350,000 | 17,500 (Direct) | View |
| 2021-03-30 Purchase | 2021-04-01 6:16 pm | Design Therapeutics Inc. | DSGN | Shah Pratik Chairman | 25,000 | $20 | $500,000 | 25,000 (Indirect Direct) | View |
| 2021-03-30 Purchase | 2021-04-01 6:17 pm | Design Therapeutics Inc. | DSGN | LAPPE RODNEY W Director | 5,000 | $20 | $100,000 | 97,024 (Direct) | View |
| 2021-03-30 Purchase | 2021-04-01 6:18 pm | Design Therapeutics Inc. | DSGN | George Simeon Director 10% Owner | 250,000 | $20 | $5,000,000 | 5,626,476 (Indirect) | View |
| 2021-03-30 Purchase | 2021-04-01 6:19 pm | Design Therapeutics Inc. | DSGN | Xu Stella Director 10% Owner | 10,000 | $20 | $200,000 | 4,730,830 (Indirect) | View |
| 2021-03-30 Purchase | 2021-04-01 6:23 pm | Design Therapeutics Inc. | DSGN | SR One Capital Fund I Aggregator LP SR ONE CAPITAL PARTNERS I LP SR ONE CAPITAL MANAGEMENT LLC 10% Owner | 250,000 | $20 | $5,000,000 | 5,626,476 (Direct) | View |
| 2021-03-30 Purchase | 2021-04-01 6:35 pm | Design Therapeutics Inc. | DSGN | Jeffries Sean COO | 3,050 | $20 | $61,000 | 3,050 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-03-25 Option Award | 2021-03-29 5:52 pm | N/A 2031-03-24 | Design Therapeutics Inc. | DSGN | George Simeon Director 10% Owner | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-03-25 Option Award | 2021-03-29 5:54 pm | N/A 2031-03-24 | Design Therapeutics Inc. | DSGN | LAPPE RODNEY W Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-03-25 Option Award | 2021-03-29 5:55 pm | N/A 2031-03-24 | Design Therapeutics Inc. | DSGN | Schmid John P. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-03-25 Option Award | 2021-03-29 5:56 pm | N/A 2031-03-24 | Design Therapeutics Inc. | DSGN | William Arsani Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-03-25 Option Award | 2021-03-29 6:31 pm | N/A 2031-03-24 | Design Therapeutics Inc. | DSGN | Xu Stella Director 10% Owner | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-03-30 Conversion | 2021-04-01 4:15 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Former 10% Owner | 4,364,844 | $0 | 4,364,844 (Indirect) | View |
| 2021-03-30 Conversion | 2021-04-01 4:15 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Former 10% Owner | 2,959,891 | $0 | 0 (Indirect) | View |
| 2021-03-30 Conversion | 2021-04-01 4:15 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Former 10% Owner | 1,404,953 | $0 | 0 (Indirect) | View |
| 2020-03-30 Conversion | 2021-04-01 6:12 pm | N/A N/A | Design Therapeutics Inc. | DSGN | William Arsani Director | 1,217,627 | $0 | 1,217,627 (Indirect) | View |
| 2020-03-30 Conversion | 2021-04-01 6:12 pm | N/A N/A | Design Therapeutics Inc. | DSGN | William Arsani Director | 814,874 | $0 | 2,032,501 (Indirect) | View |
| 2020-03-30 Conversion | 2021-04-01 6:12 pm | N/A N/A | Design Therapeutics Inc. | DSGN | William Arsani Director | 1,984,733 | $0 | 0 (Indirect) | View |
| 2020-03-30 Conversion | 2021-04-01 6:12 pm | N/A N/A | Design Therapeutics Inc. | DSGN | William Arsani Director | 1,328,245 | $0 | 0 (Indirect) | View |
| 2021-03-30 Conversion | 2021-04-01 6:16 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Shah Pratik Chairman | 104,923 | $0 | 129,923 (Indirect) | View |
| 2021-03-30 Conversion | 2021-04-01 6:16 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Shah Pratik Chairman | 171,025 | $0 | 0 (Indirect) | View |
| 2021-03-30 Conversion | 2021-04-01 6:18 pm | N/A N/A | Design Therapeutics Inc. | DSGN | George Simeon Director 10% Owner | 4,439,839 | $0 | 4,439,839 (Indirect) | View |
| 2021-03-30 Conversion | 2021-04-01 6:18 pm | N/A N/A | Design Therapeutics Inc. | DSGN | George Simeon Director 10% Owner | 936,637 | $0 | 5,376,476 (Indirect) | View |
| 2021-03-30 Conversion | 2021-04-01 6:18 pm | N/A N/A | Design Therapeutics Inc. | DSGN | George Simeon Director 10% Owner | 7,236,938 | $0 | 0 (Indirect) | View |
| 2021-03-30 Conversion | 2021-04-01 6:18 pm | N/A N/A | Design Therapeutics Inc. | DSGN | George Simeon Director 10% Owner | 1,526,718 | $0 | 0 (Indirect) | View |
| 2021-03-30 Conversion | 2021-04-01 6:19 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Xu Stella Director 10% Owner | 4,439,839 | $0 | 4,439,839 (Indirect) | View |
| 2021-03-30 Conversion | 2021-04-01 6:19 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Xu Stella Director 10% Owner | 280,991 | $0 | 4,720,830 (Indirect) | View |
| 2021-03-30 Conversion | 2021-04-01 6:19 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Xu Stella Director 10% Owner | 7,236,938 | $0 | 0 (Indirect) | View |
| 2021-03-30 Conversion | 2021-04-01 6:19 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Xu Stella Director 10% Owner | 458,016 | $0 | 0 (Indirect) | View |
| 2021-03-30 Conversion | 2021-04-01 6:23 pm | N/A N/A | Design Therapeutics Inc. | DSGN | SR One Capital Fund I Aggregator LP SR ONE CAPITAL PARTNERS I LP SR ONE CAPITAL MANAGEMENT LLC 10% Owner | 4,439,839 | $0 | 4,439,839 (Direct) | View |
| 2021-03-30 Conversion | 2021-04-01 6:23 pm | N/A N/A | Design Therapeutics Inc. | DSGN | SR One Capital Fund I Aggregator LP SR ONE CAPITAL PARTNERS I LP SR ONE CAPITAL MANAGEMENT LLC 10% Owner | 936,637 | $0 | 5,376,476 (Direct) | View |
| 2021-03-30 Conversion | 2021-04-01 6:23 pm | N/A N/A | Design Therapeutics Inc. | DSGN | SR One Capital Fund I Aggregator LP SR ONE CAPITAL PARTNERS I LP SR ONE CAPITAL MANAGEMENT LLC 10% Owner | 7,236,938 | $0 | 0 (Direct) | View |
| 2021-03-30 Conversion | 2021-04-01 6:23 pm | N/A N/A | Design Therapeutics Inc. | DSGN | SR One Capital Fund I Aggregator LP SR ONE CAPITAL PARTNERS I LP SR ONE CAPITAL MANAGEMENT LLC 10% Owner | 1,526,718 | $0 | 0 (Direct) | View |
| 2021-03-30 Conversion | 2021-04-01 6:25 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Quan Venture Fund II L.P. 10% Owner | 4,439,839 | $0 | 4,439,839 (Direct) | View |
| 2021-03-30 Conversion | 2021-04-01 6:25 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Quan Venture Fund II L.P. 10% Owner | 280,991 | $0 | 4,720,830 (Direct) | View |
| 2021-03-30 Conversion | 2021-04-01 6:25 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Quan Venture Fund II L.P. 10% Owner | 7,236,938 | $0 | 0 (Direct) | View |
| 2021-03-30 Conversion | 2021-04-01 6:25 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Quan Venture Fund II L.P. 10% Owner | 458,016 | $0 | 0 (Direct) | View |